These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 33140987)

  • 1. Localised neuropathic pain in the primary care setting: a cross-sectional study of prevalence, clinical characteristics, treatment patterns, quality of life and sleep performance.
    Mick G; Serpell M; Baron R; Mayoral V; Hans G; Mendez I; Artime E; Qizilbash N; Sohns M
    Curr Med Res Opin; 2021 Feb; 37(2):293-302. PubMed ID: 33140987
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence and characterization of neuropathic pain in a primary-care setting in Spain: a cross-sectional, multicentre, observational study.
    Pérez C; Saldaña MT; Navarro A; Vilardaga I; Rejas J
    Clin Drug Investig; 2009; 29(7):441-450. PubMed ID: 19499961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pregabalin beneficial effects on sleep quality or health-related quality of life are poorly correlated with reduction on pain intensity after an 8-week treatment course.
    Perez-Lloret S; Rojas GM; Menoni MC; Ruiz G; Velásquez C; Rodriguez H; Rey MV; Cardinali AD;
    Clin Neuropharmacol; 2012; 35(1):21-4. PubMed ID: 22156921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness of the capsaicin 8% patch in the management of peripheral neuropathic pain in European clinical practice: the ASCEND study.
    Mankowski C; Poole CD; Ernault E; Thomas R; Berni E; Currie CJ; Treadwell C; Calvo JI; Plastira C; Zafeiropoulou E; Odeyemi I
    BMC Neurol; 2017 Apr; 17(1):80. PubMed ID: 28431564
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuropathic cancer pain: prevalence, severity, analgesics and impact from the European Palliative Care Research Collaborative-Computerised Symptom Assessment study.
    Rayment C; Hjermstad MJ; Aass N; Kaasa S; Caraceni A; Strasser F; Heitzer E; Fainsinger R; Bennett MI;
    Palliat Med; 2013 Sep; 27(8):714-21. PubMed ID: 23175513
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological target therapy of neuropathic pain and patient-reported outcomes in patients with chronic low back pain in Korea: Results from the NLBP Outcomes Research.
    Hong JT; Kim JH; Kim KS; Lee CS; Shin HC; Kim WK; Kim JH; Lee JK; Kim IS; Ha Y; Im SB; Kim SW; Han IH; Shin JJ; Rim B; Suk KS; Kim JH; Park YS; Chang BS; Jun DS; Kim YH; Lee JH; Min WK; Lee JS; Park SY; Oh IS; Hong JY; Seo BJ; Kim YJ; Lee J
    Medicine (Baltimore); 2018 Aug; 97(35):e11919. PubMed ID: 30170385
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical characteristics and pain management among patients with painful peripheral neuropathic disorders in general practice settings.
    Gore M; Dukes E; Rowbotham DJ; Tai KS; Leslie D
    Eur J Pain; 2007 Aug; 11(6):652-64. PubMed ID: 17126045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuropathic Pain Components in Patients with Cancer: Prevalence, Treatment, and Interference with Daily Activities.
    Oosterling A; te Boveldt N; Verhagen C; van der Graaf WT; Van Ham M; Van der Drift M; Vissers K; Engels Y
    Pain Pract; 2016 Apr; 16(4):413-21. PubMed ID: 25857631
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and tolerability of pregabalin using a flexible, optimized dose schedule in Korean patients with peripheral neuropathic pain: a 10-week, randomized, double-blind, placebo-controlled, multicenter study.
    Moon DE; Lee DI; Lee SC; Song SO; Yoon DM; Yoon MH; Kim HK; Lee YW; Kim C; Lee PB
    Clin Ther; 2010 Dec; 32(14):2370-85. PubMed ID: 21353106
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medication and treatment use in primary care patients with chronic pain of predominantly neuropathic origin.
    Torrance N; Smith BH; Watson MC; Bennett MI
    Fam Pract; 2007 Oct; 24(5):481-5. PubMed ID: 17670804
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gabapentin effect on neuropathic pain compared among patients with spinal cord injury and different durations of symptoms.
    Ahn SH; Park HW; Lee BS; Moon HW; Jang SH; Sakong J; Bae JH
    Spine (Phila Pa 1976); 2003 Feb; 28(4):341-6; discussion 346-7. PubMed ID: 12590206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidemiology and treatment of neuropathic pain: the UK primary care perspective.
    Hall GC; Carroll D; Parry D; McQuay HJ
    Pain; 2006 May; 122(1-2):156-62. PubMed ID: 16545908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic pain with neuropathic characteristics after surgery for major trauma to the lower limb: prevalence, predictors, and association with pain severity, disability, and quality of life in the UK WHiST trial.
    Keene DJ; Knight R; Bruce J; Dutton SJ; Tutton E; Achten J; Costa ML
    Bone Joint J; 2021 Jun; 103-B(6):1047-1054. PubMed ID: 33902306
    [TBL] [Abstract][Full Text] [Related]  

  • 14. All pain is not the same: an overview of neuropathic pain in the elderly.
    Martin CM; Saleeby LG
    Consult Pharm; 2007 Apr; 22(4):283-94. PubMed ID: 17658961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topical capsaicin (high concentration) for chronic neuropathic pain in adults.
    Derry S; Rice AS; Cole P; Tan T; Moore RA
    Cochrane Database Syst Rev; 2017 Jan; 1(1):CD007393. PubMed ID: 28085183
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current Status of Malignant Neuropathic Pain in Chinese Patients with Cancer: Report of a Hospital-based Investigation of Prevalence, Etiology, Assessment, and Treatment.
    Lu F; Song L; Xie T; Tian J; Fan Y; Liu H
    Pain Pract; 2017 Jan; 17(1):88-98. PubMed ID: 26991802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The burden of neuropathic pain: results from a cross-sectional survey.
    McDermott AM; Toelle TR; Rowbotham DJ; Schaefer CP; Dukes EM
    Eur J Pain; 2006 Feb; 10(2):127-35. PubMed ID: 16310716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A pharmacological treatment algorithm for localized neuropathic pain.
    Allegri M; Baron R; Hans G; Correa-Illanes G; Mayoral Rojals V; Mick G; Serpell M
    Curr Med Res Opin; 2016; 32(2):377-84. PubMed ID: 26641136
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of neuropathic pain in radiotherapy oncology units.
    Mañas A; Monroy JL; Ramos AA; Cano C; López-Gómez V; Masramón X; Pérez M;
    Int J Radiat Oncol Biol Phys; 2011 Oct; 81(2):511-20. PubMed ID: 20832183
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patient-reported outcomes in subjects with neuropathic pain receiving pregabalin: evidence from medical practice in primary care settings.
    Navarro A; Saldaña MT; Pérez C; Torrades S; Rejas J
    Pain Med; 2010 May; 11(5):719-31. PubMed ID: 20345618
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.